Does Maternal Synbiotic Supplementation Affect Conjugated Linoleic Acid Level in Breast Milk? A Randomized Placebo-Controlled Clinical Trial

2018 ◽  
Vol 13 (1) ◽  
pp. 81-84 ◽  
Author(s):  
Leila Nikniaz ◽  
Reza Mahdavi ◽  
Alireza Ostadrahimi ◽  
Zeinab Nikniaz ◽  
Soghra Aliasgharzadeh
Keyword(s):  
Clinical Trial ◽  
Linoleic Acid ◽  
Breast Milk ◽  
Conjugated Linoleic Acid ◽  
Acid Level ◽  
Controlled Clinical Trial ◽  
Linoleic Acid Level ◽  
Synbiotic Supplementation

204 An Investigation into the Role of Dietary Essential Fatty Acids Ratios and Linoleic Acid Level on Growth Performance and Inflammation of Grow-finish Pigs

2021 ◽  
Vol 99 (Supplement_1) ◽  
pp. 63-63
Author(s):  
Spenser Becker ◽  
Laura L Greiner
Keyword(s):  
Linoleic Acid ◽  
Synovial Fluid ◽  
Growth Performance ◽  
Repeated Measures ◽  
Fixed Effects ◽  
Acid Level ◽  
Essential Fatty Acids ◽  
Growing Pigs ◽  
Inflammatory Status ◽  
Linoleic Acid Level

Abstract The objective was to investigate the effects of dietary linoleic acid level and the ratio of linoleic acid:linolenic acid (n6:n3) on the growth performance and inflammatory status of grow-finish pigs. A total of 300 growing pigs (BW = 41.1 ± 6.3 kg) were randomly assigned to either a high (30 g/kg; HLA) or low (15 g/kg; LLA) linoleic acid level with a high (20:1; HR), moderate (12:1; MR) or low (4:1; LR) n6:n3 in a 2 x 3 factorial design. Diets were fed across three 28-day phases and were balanced for dietary metabolizable energy. Pigs were housed 5 pigs per pen. Blood samples were collected on weeks 1, 3, 6, and 12, and synovial fluid was collected from the hock joint on weeks 1 and 12 for inflammatory marker analysis. Data were analyzed as repeated measures using PROC MIXED (SAS 9.4) with initial body weight as a covariate, pen as the experimental unit, and linoleic acid level, ratio, and their interaction as fixed effects. Compared to HLA, LLA pigs had increased BW (P < 0.05) at d56 (103.2 vs. 101.3kg) and tended to have increased BW at d84 (P < 0.10; 129.1 vs. 127.8kg). Pigs receiving LR tended to have higher d84 BW compared to MR (P < 0.10; 129.1 vs. 127.3kg). There was no effect of linoleic acid ratio interaction for growth performance. In phase 2, pigs receiving LR had higher feed intake (P < 0.05) compared to MR. Pigs receiving HR performed intermediate of LR and MR. Overall, C-reactive protein was reduced in the plasma of pigs receiving HLA (P < 0.05; 19.3 vs. 26.2mg/mL). Across all treatments, CRP was reduced in synovial fluid and plasma in week 12 vs. week 1 (P < 0.05). In conclusion, LLA and a low ratio of n6:n3 improved final pig BW, and HLA is potentially beneficial in improving inflammation.

scholarly journals Does synbiotic supplementation affect the quality of life in children with cystic fibrosis? A pilot randomized controlled clinical trial

2020 ◽  
Author(s):  
Nemat Bilan ◽  
Effat Marefat ◽  
Leila Nikniaz ◽  
Mahdieh Abbasalizad Farhangi ◽  
Zeinab Nikniaz
Keyword(s):  
Quality Of Life ◽  
Clinical Trial ◽  
Cystic Fibrosis ◽  
Demographic Data ◽  
Intervention Group ◽  
Controlled Clinical Trial ◽  
Double Blind ◽  
The Mean ◽  
Synbiotic Supplementation

Abstract Background: There is no clinical trial that assesses the effect synbiotic supplementation on HRQOL in CF children. Considering the importance of HRQOL as an essential primary outcome and determinant of therapeutic benefit in chronic diseases like cystic fibrosis, the present clinical trial aimed to determine the efficacy of synbiotic supplementation on HRQOL in children with CF.Methods: In the present double-blind randomized clinical trial, 40 CF children were randomly allocated to the two groups. The intervention group was supplemented with synbiotics supplements and the patients in the placebo group received maltodextrin for six months. Demographic data and information about antibiotic use were recorded using the questionnaire. The health-related quality of life was assessed using the Persian version of quality of life inventory questionnaires. Paired t-test and ANCOVA were used for statistical analysis. Results: Totally, 36 participants completed the trial. The mean score of HRQOL was 76.34±17.33. There were no significant differences between synbiotic and placebo groups regarding baseline demographic and quality of life characteristics. Compared with baseline values, the mean total score and subscores of quality of life did not change significantly after synbiotic and placebo supplementation (p>0.05). Moreover, the results of ANCOVA showed that there were no significant differences between the two groups regarding the post-trial value of HRQOL total score and subscores. Conclusion: According to results, six-month supplementation with synbiotic did not have a significant effect on the HRQOL in children with CF. However, further studies with larger sample sizes and using more disease-specific questionnaires are needed for a more precise conclusion. The protocol of the study was registered at Iranian registry clinical trials (Registration code: IRCT2017011732004N1; Registration date: 2017-02-14).

scholarly journals Does Synbiotic Supplementation Affect the Quality of Life in Children with Cystic Fibrosis? A Pilot Randomized Controlled Clinical Trial

2020 ◽  
Author(s):  
Nemat Bilan ◽  
Effat Marefat ◽  
Leila Nikniaz ◽  
Mahdieh Abbasalizad Farhangi ◽  
Zeinab Nikniaz
Keyword(s):  
Quality Of Life ◽  
Clinical Trial ◽  
Cystic Fibrosis ◽  
Demographic Data ◽  
Intervention Group ◽  
Controlled Clinical Trial ◽  
Double Blind ◽  
The Mean ◽  
Synbiotic Supplementation

Abstract Background There is no clinical trial that assesses the effect synbiotic supplementation on HRQOL in CF children. Considering the importance of HRQOL as an essential primary outcome and determinant of therapeutic benefit in chronic diseases like cystic fibrosis, the present clinical trial aimed to determine the efficacy of synbiotic supplementation on HRQOL in children with CF.Methods In the present double-blind randomized clinical trial, 40 CF children were randomly allocated to the two groups. The intervention group was supplemented with synbiotics supplements and the patients in the placebo group received maltodextrin for six months. Demographic data and information about antibiotic use were recorded using the questionnaire. The health-related quality of life was assessed using the Persian version of quality of life inventory questionnaires. Paired t-test and ANCOVA were used for statistical analysis.Results Totally, 36 participants completed the trial. The mean score of HRQOL was 76.34 ± 17.33. There were no significant differences between synbiotic and placebo groups regarding baseline demographic and quality of life characteristics. Compared with baseline values, the mean total score and subscores of quality of life did not change significantly after probiotic and placebo supplementation (p > 0.05). Moreover, the results of ANCOVA showed that there were no significant differences between the two groups regarding the post-trial value of HRQOL total score and subscores.Conclusion According to results, six-month supplementation with synbiotic did not have a significant effect on the HEQOL in children with CF. However, further studies with larger sample sizes and using more disease-specific questionnaires are needed for a more precise conclusion.

Sign in / Sign up

Export Citation Format

Share Document